$543.150
+10.211 (+1.88%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
UTHR Prediction & Forecast by Similar Chart Analysis
Alphio's UTHR stock price prediction model matches the current United Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $564.63 (+1.94%). The 1-week path is $546.57 (-1.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy United Therapeutics Corp Stock?
United Therapeutics Corp is currently a hold. The stock is priced at $533.12, which is below several analyst price targets, including $728 from BTIG and $708 from RBC Capital. However, the RSI is at 45.857, indicating that the stock is neither overbought nor oversold, suggesting caution. The recent settlement with Liquidia has removed significant legal uncertainties, but the stock has seen a 2.92% decline over the last five days, indicating potential short-term volatility. The main risk is the Goldman Sachs target of $321, representing a 34% downside from current levels, which investors should consider before making a decision.
UTHR stock price ended at $543.15 on Monday, after rising +1.88%
United Therapeutics Corp (UTHR) last closed at $553.88, gaining +1.98%. These facts feed the 1-day and 1-week UTHR price prediction above.
Analyst Consensus
United Therapeutics Corp (UTHR): 2 buy, 6 hold, 5 sell. Outlook: Sell.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
United Therapeutics Corp (UTHR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches UTHR, ranked by similarity.
Seasonality analysis for UTHR
Historically the probability of a positive October return for UTHR is 100.00%. October offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for UTHR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $367.94 | $404.09 | $458.71 | -27.04% |
| Nov 2026 | $341.08 | $357.40 | $360.53 | -35.47% |
| Dec 2026 | $399.83 | $429.48 | $447.75 | -22.46% |
In 2026, United Therapeutics Corp (UTHR) is projected to range from $341.08 to $458.71.
United Therapeutics Corp 2026 monthly forecast
In Oct 2026, United Therapeutics Corp is projected to average $404.09, with a low of $367.94 and high of $458.71.
In Nov 2026, United Therapeutics Corp is projected to average $357.40, with a low of $341.08 and high of $360.53.
In Dec 2026, United Therapeutics Corp is projected to average $429.48, with a low of $399.83 and high of $447.75.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.